L.D.W. van den Dungen

Statistics

Publications

Citations

124

H-Index

Active since

2024

Affiliations

Oncode Institute(Current)

OLVG

Spaarne Ziekenhuis

L.D.W. van den Dungen is an author at Oncode Institute specializing in colorectal cancer adjuvant therapy, gastrointestinal oncology, and colorectal cancer neoadjuvant therapy.

Publications per year

2024–2024

Publications

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial

P.G.M. de Gooyer, Y.L. Verschoor, L.D.W. van den Dungen et al. · Nature Medicine · 2024 · 102 citations · Full text

Medicine, Immunology, Oncology +16

LBA24 Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: 3-year disease-free survival from NICHE-2

Myriam Chalabi, L.D.W. van den Dungen, Y.L. Verschoor et al. · Annals of Oncology · 2024 · 22 citations

Medicine, Immunology, Oncology +15

1–2 of 2